Tang et al. showed that AML cells expressed high levels of CD44 mRNA, and the expression of AML-derived FLT3 and DNMT3A mutants promote the transcription of CD44 mRNA through suppression of CpG island methylation in the CD44 promoter [60]. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.